Establishing a more translationally aligned approach through cross-sector collaboration is essential for identifying neurological risks before a drug reaches human clinical trials. The central nervous system remains the most daunting frontier in drug development due to its sheer structural
The intersection of rapid technological disruption and a purging of the federal workforce has created a policy vacuum that threatens the nation's response to synthetic viruses. Current shifts in the American national security posture indicate a systematic dismantling of the biological defense
The proliferation of over one thousand high-containment laboratories in the United States since 9/11 has paradoxically increased the mathematical probability of a catastrophic accident. This startling statistic serves as the foundation for Annie Jacobsen’s investigation into the burgeoning threat
Historical failures in the vitiligo pipeline, such as the cancellation of the AC##4 trial in 2016, highlight the difficulty of establishing a global site network. The recent publication of the Viti-Up Phase 3 clinical trial results in The Lancet marks a transformative moment for dermatologic
For the 15,000 Americans living with Duchenne muscular dystrophy, the three-month regulatory delay represents a critical window where irreversible physical decline remains a constant threat. This extension, moving the target decision date from August to November 22, 2026, occurred after the Food
The RAND Corporation warns that current AI capabilities in applied biological sciences could soon enable the creation of catastrophic health threats. Rapid advancements in Large Language Models (LLMs) and Biological Design Tools (BDTs) have fundamentally altered the landscape of biosecurity. These
